# SPECIAL INVESTIGATION FOR ABRYSVO IN PREGNANT WOMEN AND INFANTS

> **NCT06482099** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 497 (actual)

## Conditions studied

- Respiratory Tract Infection

## Interventions

- **BIOLOGICAL:** RSVpreF vaccine

## Key facts

- **NCT ID:** NCT06482099
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-10-01
- **Primary completion:** 2026-02-27
- **Final completion:** 2026-02-27
- **Target enrollment:** 497 (ACTUAL)
- **Last updated:** 2026-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06482099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06482099, "SPECIAL INVESTIGATION FOR ABRYSVO IN PREGNANT WOMEN AND INFANTS". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06482099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*